← All organizations
Highest phase reached
Phase 3
First clinical trial
May 10, 2019Last known activity
Mar 20, 2021
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 3 trials)
Phase 3 (2 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (4)
- NCT05824039CollaboratorN/AMar 20, 2021
- NCT04405921Reponsible party - principal investigatorPhase 3May 31, 2020
- NCT04405921Lead sponsorPhase 3May 31, 2020
- NCT05406960CollaboratorN/AMay 10, 2019
Details
- Last known activity
- Mar 20, 2021